Simon Barry J. 4
4 · ImmunityBio, Inc. · Filed Jan 24, 2025
Insider Transaction Report
Form 4
Simon Barry J.
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2025-01-22−110,020→ 0 totalExercise: $2.00Exp: 2025-02-16→ Common Stock (110,020 underlying) - Exercise/Conversion
Common Stock
2025-01-22$2.00/sh+110,020$219,864→ 3,233,781 total
Footnotes (2)
- [F1]Cash exercise of options scheduled to expire on February 16, 2025.
- [F2]Subject to the reporting person's continuing service, one twenty-fourth (1/24th) of the shares subject to the option vested each month on the same day as the vesting commencement date, such that the shares subject to the option became fully vested and exercisable on the second (2nd) anniversary of the vesting commencement date. The vesting commencement date for this option was January 16, 2015.